IRVINE, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) — Beta Bionics, Inc. (Nasdaq: BBNX) today announced the pricing of an underwritten public offering of 7,652,175 shares of its common stock at a price to the public of $17.25 per share and, in lieu of shares of common stock to certain investors, pre-funded warrants to purchase 1,043,484 shares of common stock at a purchase price of $17.2499 per share, which equals the public offering price per share of the common stock less the $0.0001 exercise price per share of each pre-funded warrant. The gross proceeds from this offering are expected to be $150.0 million, before deducting underwriting discounts and commissions and offering expenses payable by Beta Bionics. The offering is expected to close on or about September 17, 2026, subject to customary closing conditions. In addition, Beta Bionics has granted the underwriters for the offering a 30-day option to purchase up to 1,304,348 additional shares of its common stock at the public offering price, less the underwriting discounts and commissions.

Beta Bionics expects to use the net proceeds from this offering for general corporate purposes, which may include costs associated with the commercialization of MintTM, including expansion of Beta Bionics’ manufacturing facilities, research and development and clinical development, investment in product enhancements, potential strategic opportunities and working capital and operating expenses.

J.P. Morgan, Piper Sandler, Wells Fargo Securities and Leerink Partners are acting as the joint book-running managers for the offering.

The shares of common stock and pre-funded warrants described above are being offered by Beta Bionics pursuant to a shelf registration statement on Form S-3 that was filed by Beta Bionics with the Securities and Exchange Commission (SEC) on February 24, 2026 and automatically became effective upon filing. A final prospectus supplement related to the offering will be filed with the SEC and will be available on the SEC’s website located at http://www.sec.gov. Copies of the final prospectus supplement and the accompanying prospectus related to this offering, when available, may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by email at prospectus-eq_fi@jpmchase.com and postsalemanualrequests@broadridge.com; or from Piper Sandler & Co., 350 North 5th Street, Suite 1000, Minneapolis, Minnesota 55401, Attention: Prospectus Department, by telephone at (800) 747-3924, or by email at prospectus@psc.com; or from Wells Fargo Securities, LLC, Attention: Wells Fargo Securities, 90 South 7th Street, 5th Floor, Minneapolis, Minnesota 55402, by telephone at 800-645-3751 (option #5), by email at WFScustomerservice@wellsfargo.com; or from Leerink Partners LLC, Attention: Syndicate Department, 53 State Street, 40th Floor, Boston, Massachusetts 02109, by telephone at (800) 808-7525, ext. 6105, or by email at syndicate@leerink.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Beta Bionics
Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines every insulin dose and offers the potential to substantially improve overall outcomes across broad populations of PWD.

Cautionary Note on Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. These statements may be identified by introductory words such as “may,” “expects,” “goal,” “intend,” “will,” “would,” “subject to” or words of similar meaning, or by the fact that they do not relate strictly to historical or current facts. Such forward-looking statements include statements regarding Beta Bionics’ expectations with respect to the completion, timing and size of the public offering, and the use of proceeds from the offering. For such statements, Beta Bionics claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Beta Bionics’ expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, changes in market conditions, the risk that the offering will not be consummated on the timing contemplated or otherwise, and the satisfaction of customary closing conditions related to the offering, as well as the risks and uncertainties discussed in the preliminary prospectus supplement for the offering and other risks and uncertainties disclosed in Beta Bionics’ filings with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 24, 2026, as updated by its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, filed with the SEC on July 29, 2026, and other filings that Beta Bionics may make from time to time with the SEC. These forward-looking statements represent Beta Bionics’ judgment as of the time of this release. Beta Bionics disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

Investor Relations:
Blake Beber
Head of Investor Relations
ir@betabionics.com

Media and Public Relations:
Felicia Sanborn
Vice President of Marketing
media@betabionics.com

Phoenix, AZ, Sept. 15, 2026 (GLOBE NEWSWIRE) — InnSuites Hospitality Trust (NYSE American: IHT) announced record Fiscal 2027 (February 1, 2026 through January 31, 2027) First Fiscal Half Total Revenues of $4,099,593.

Consolidated Net Income before non-cash items primarily consisting of depreciation was $120,280 for the 2027 First Fiscal Half ended July 31, 2026. This represents an increase of $178,057 over the prior year.

Combined Hotel Occupancy was 83.42% for the First Fiscal Half of Fiscal Year 2027, which was approximately a 3.04% increase from the prior First Fiscal Half, while the Revenue Per Available Room and Suites (REVPAR), modestly increased from $78.48 to $79.66 over this same period.

IHT hotel operations were strong in the 2026 Fiscal Year ended January 31, 2026, and contributed to a steady First Half in the current 2027 Fiscal Year. Combined Hotel August Revenue for both hotels was $513,145, which led to total Hotel Revenue of approximately $4.5 million for the First Seven Fiscal Months of Fiscal 2027, a combined record. IHT’s strong hotel operating results are reflected in three of the five most recent Fiscal Years profitable, even after accounting for substantial depreciation and other non-cash expenses. These are positive signs for InnSuites, as progress remains strong, despite 2026 Travel Industry uncertainty.

On August 19, 2026, the Trust increased its shareholders’ equity by $3 million and reduced debt by $3 million.

InnSuites Hospitality Trust continues to explore diversification opportunities and opportunities to increase Equity, potentially including a merger or reverse merger, which is of high interest.

The continued growing demand for electricity from data centers plus the influx of electric vehicles, as well as projected growing needs for artificial intelligence, increased demand for electricity over the next five years is projected to approximately double, and bodes well for the IHT investment in UniGen Power, Inc. This product is a potentially power industry disruptive economical, relatively clean energy, cost effective electric generation innovation. Even though it is high risk, UniGen offers IHT high upside potential.

On February 20, 2026, James Wirth, IHT President, was elected Chairman, CEO, and President of UniGen, while Marc Berg, IHT EVP, was elected as Vice Chairman, EVP, and Secretary/Treasurer of UniGen, with plans to rejuvenate the UniGen progress, while also holding all the UniGen Board seats.

On March 5, 2025, REF, an investment entity owned by the chairman and family of IHT majority IHT shareholder, purchased IBC Hotels, LLC, and hired RRF LLLP, the management company subsidiary of InnSuites Hospitality Trust (IHT), to manage the rebirth of IBC. In the process, RRF LLLP, obtained a five-year option to purchase, at cost, IBC Hotels, LLC. This option is believed to provide IHT a valuable upside opportunity, if successful, to profit from the revitalization of InnDependent Boutique Collection (IBC Hotels).

IHT management believes that due to real estate held on the books of IHT at book values significantly below current market value, due to clean energy diversification high profit potential ahead, IBC independent hotel services prospects, a potential merger or reverse merger future, plus improving hospitality profitability before non-cash depreciation and other non-cash items, along with the recent increase of IHT equity of $3 million, the IHT future looks bright.

IHT future plans include continuation of its uninterrupted annual dividend, beginning in its inception in 1971, with the next dividend tentatively scheduled for February 15, 2027, at the beginning of the 2028 Fiscal Year.

Management believes that the Trust’s hotel operating results, real estate assets, capitalization initiatives, and strategic alternatives provide a positive basis for future of the Trust. There can be no assurance that any of these initiatives will be successful, that the Trust will complete any equity-enhancing transaction, or that the Trust will regain or maintain compliance with NYSE American continued listing standards.

For more information, visit www.innsuitestrust.com and www.innsuites.com.

Forward-Looking Statements

With the exception of historical information, matters discussed in this news release may include “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements include, without limitation, statements regarding the Trust’s intended submission of a compliance plan to NYSE American; the Trust’s ability to regain compliance with NYSE American continued listing standards; potential actions to increase stockholders’ equity; potential conversion of related-party indebtedness into IHT equity; potential capital-raising, capitalization restructuring, or strategic transactions; potential merger or reverse merger opportunities; operating initiatives; hotel operating trends; future annual dividends; diversification opportunities; opportunities involving IBC Hotels, LLC and UniGen Power, Inc.; and expected costs, benefits, timing, or results of any of the foregoing.

Actual developments, business decisions, results, and future actions may differ materially from those expressed or implied by such forward-looking statements. Important factors, among others, that could cause actual results and future actions to differ materially include: NYSE American’s review of the Trust’s compliance plan; the Trust’s ability to complete any equity-enhancing transaction; the Trust’s ability to regain and maintain compliance with NYSE American continued listing standards; the availability, terms, and timing of financing or capitalization alternatives; the outcome of any related-party transaction review; accounting treatment of proposed transactions; required board, committee, NYSE American, shareholder, or other approvals; market conditions; hotel operating results; seasonality; liquidity needs; the outcome of any merger or reverse merger or strategic transaction discussions; the timing and success of potential diversification initiatives; risks relating to IBC Hotels, LLC and UniGen Power, Inc.; economic effects of international conflicts, tariffs, inflation, interest rates, travel industry conditions, and other macroeconomic factors; and the risks described in the Trust’s filings with the Securities and Exchange Commission.

The Trust undertakes no obligation to update any forward-looking statement contained in this news release to reflect events or circumstances after the date of this news release, except as required by applicable law.

FOR FURTHER INFORMATION:

Marc Berg, Executive Vice President
602-944-1500
email: mberg@innsuites.com

INNSUITES HOSPITALITY CENTRE
1730 E. NORTHERN AVENUE, #122
Phoenix, Arizona 85020
Phone: 602-944-1500

NEW YORK and HONG KONG, Sept. 15, 2026 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Apollo-managed funds, affiliates, and other long-term investors provided a $585 million financing to The Executive Centre (“TEC”), one of Asia’s leading providers of premium flexible office space, with more than 30 years of operating experience and a portfolio of over 260 centres across 38 cities in 15 markets across APAC and the Middle East. Proceeds will be primarily used to refinance existing debt and positions TEC for further expansion to meet sustained demand for premium flexible office spaces in the region.

“We are excited to deliver a tailored solution to The Executive Centre that supports their business needs and long-term strategic objectives,” said Celia Yan, Partner and Co-Head of APAC Credit & Hybrid at Apollo. “Bespoke hybrid solutions require deep cross-collaboration and the ability to understand both investors and management teams alike, and we are pleased to be TEC’s partner of choice for this transaction.”

“TEC has spent three decades building a trusted platform for multinational clients who need the flexibility to scale across Asia. Apollo’s ability to deliver a solution signals confidence and addresses both our refinancing objectives and growth ambitions, reflecting the long-term, partnership-driven approach we were looking for,” a spokesperson for The Executive Centre stated.

The investment builds on Apollo’s track record of hybrid capital solutions in Asia including transactions with JSW Cement, Global Schools Group, Hero FinCorp, HMI/PanAsia Health, Molycop and Charles Monat Associates.

A&O Shearman acted as legal counsel to Apollo. Clifford Chance acted as legal counsel and Rippledot Capital as financial advisor to The Executive Centre.

About Apollo
Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade credit to private equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clients and provided businesses with innovative capital solutions for growth. Through Athene, our retirement services business, we specialize in helping clients achieve financial security by providing a suite of retirement savings products and acting as a solutions provider to institutions. Our patient, creative, and knowledgeable approach to investing aligns our clients, businesses we invest in, our employees, and the communities we impact, to expand opportunity and achieve positive outcomes. As of June 30, 2026, Apollo had approximately $1.05 trillion of assets under management. To learn more, please visit www.apollo.com.

Contacts

Noah Gunn
Global Head of Investor Relations
+1 (212) 822-0540
IR@apollo.com

Joanna Rose
Global Head of Corporate Communications
+1 (212) 822-0491
Communications@apollo.com

SANTA ANA, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) — TTM Technologies, Inc. (NASDAQ: TTMI) (“TTM”), a leading global manufacturer of technology products, including mission systems, radio frequency (“RF”) components, RF microwave/microelectronic assemblies, and technologically advanced interconnect products, including printed circuit boards (“PCB” s) and substrates, will exhibit at the electronica India 2026 trade fair, at Hall 3, Booth B11, from September 16–18, 2026, at the Bangalore International Exhibition Centre, Bangalore, India.

As the electronics industry accelerates toward smarter, faster, and more connected solutions, TTM continues to expand its capabilities and global reach to meet the growing customer demand. TTM will showcase its latest advancements in interconnect and innovative solutions at South Asia’s leading electronics trade fair, bringing to market technologies that address the industry’s most pressing design challenges, including high-speed PCB technology for AI and hyperscale data centers, advanced interconnect and system integration, and next-generation RF and microwave technologies. Among TTM’s latest innovative solutions are its N+M asymmetric PCB technologies, which enable customers to optimize signal integrity and power delivery within a single board, delivering the performance and density that today’s AI infrastructure and advanced electronics applications demand.

“Electronica has long been an important platform for TTM to connect with the global electronics community, and we are proud to bring that presence to India again. electronica India represents a tremendous opportunity to engage with the rapidly expanding electronics industry in this market. We look forward to collaborating with industry leaders and demonstrating how our advanced PCB technologies and innovative solutions can empower businesses to stay ahead in a rapidly evolving marketplace,” said Laura Woods, Vice President, Corporate Sales & Sales Operations at TTM Technologies.

TTM’s expert team will be at the exhibition throughout the event for conversations about emerging trends and future developments shaping the next wave of electronics innovation. To schedule a meeting with TTM at electronica India 2026, please visit: electronica India 2026 | TTM Technologies

About TTM

TTM Technologies, Inc. is a leading global manufacturer of technology products, including mission systems, radio frequency (“RF”) components, RF microwave/microelectronic assemblies, and technologically advanced interconnect products, including PCBs and substrates. TTM stands for time-to-market, representing how TTM’s time-critical, one-stop design, engineering and manufacturing services enable customers to reduce the time required to develop new products and bring them to market. Additional information can be found at www.ttm.com

Contacts:         
Winnie Ng
Vice President, Corporate Marketing
TTM Technologies, Inc.
+852 22722287 / +1 714 327 3000
winnie.ng@ttm.com
Sean K.F. Hannan,
Vice President, Investor Relations
TTM Technologies, Inc.
+1 339 466 7737
sean.hannan@ttmtech.com

The transaction will support Reliance’s next phase of growth as a global leader in plumbing products and solutions

NEW YORK and SYDNEY, Sept. 15, 2026 (GLOBE NEWSWIRE) — Brookfield, through its flagship private equity strategy, today announced that it has entered into an agreement to acquire 100% of global manufacturer of plumbing and heating solutions Reliance Worldwide Corporation (“Reliance”) (ASX: RWC).

The Reliance Board has unanimously recommended the all-cash proposal of US$3.38 per share to shareholders, who will vote on the agreement. The proposal constitutes an enterprise value for Reliance of approximately US$2.8 billion.

Reliance is headquartered in the US, with operations across the Americas, Europe and the Middle East (EMEA), and Asia Pacific.

Anuj Ranjan, CEO of Brookfield’s Private Equity group, said:

“Reliance is the type of business we look for – a global, market-leading industrial company with strong brands, durable customer relationships and clear opportunities to create value through investment in operations and continued product expansion. Brookfield’s global operating expertise in industrials and the US housing ecosystem positions us well to support Reliance in its next phase of growth and over the long term.”

Investment Highlights

  • Market leader: The market leader in push-to-connect (“PTC”) fittings for plumbing systems, with category-defining brands across the Americas, EMEA and APAC. The PTC segment remains underpenetrated relative to traditional joining methods.
  • Adjacent products: Proven model to expand non-PTC products to existing customers, supported by strong position with major retailers and the wholesale channel.
  • Industry tailwinds: Resilient cashflows underpinned by recurring replacement needs in aging housing stocks. A new generation of trades professionals are more receptive to the core PTC products, which increases a long-term demand tailwind.

Transaction Details

Brookfield’s investment will be funded through the Brookfield Capital Partners strategy and its affiliate Brookfield Business Corporation (NYSE: BBUC, TSX: BBUC).

The transaction remains subject to customary closing conditions including shareholder, regulatory and government approvals. Subject to the necessary approvals, the transaction is expected to close in Q1 2027.

About Brookfield

Brookfield is a leading global investment firm, headquartered in New York, with more than $1 trillion in assets under management. The firm owns and operates high-quality businesses and real assets that provide essential services and form the backbone of the global economy. Brookfield invests on behalf of institutions and individuals around the world across infrastructure, energy, private equity, real estate, and credit. With more than a century of operating experience and a global presence in over 50 countries, Brookfield deploys long-term capital to generate sustainable value for its clients and shareholders. Brookfield Corporation (NYSE: BN, TSX: BN) and Brookfield Asset Management (NYSE: BAM, TSX: BAM) are publicly traded in New York and Toronto.

For more information, please visit our website at www.brookfield.com.

Brookfield Media:

Catherine Woods
Tel: +61 477 320 333
Email: catherine.woods@brookfield.com

Simon Maine
Tel: +1 332 298 0447
Email: simon.maine@brookfield.com

Brookfield Investor Relations:

Alan Fleming (BBUC)
Tel: +1 416 645 2736
Email: alan.fleming@brookfield.com

Jason Fooks (BAM)
Tel: +1 212 417 2442
Email: jason.fooks@brookfield.com

   

Notice to Readers

This press release contains “forward-looking statements” within the meaning of the U.S. Securities Act of 1933, the U.S. Securities Exchange Act of 1934, “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of other relevant securities legislation, including applicable securities laws in Canada, which reflect our current views with respect to, among other things, our operations and financial performance (collectively, “forward-looking statements”). Forward-looking statements include statements that are predictive in nature, depend upon or refer to future results, events or conditions, and include, but are not limited to, statements which reflect management’s current estimates, beliefs and assumptions and which are in turn based on our experience and perception of historical trends, current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. The estimates, beliefs and assumptions of Brookfield are inherently subject to significant business, economic, competitive and other uncertainties and contingencies regarding future events and as such, are subject to change. Forward-looking statements are typically identified by words such as “expect”, “anticipate”, “believe”, “foresee”, “could”, “estimate”, “goal”, “intend”, “plan”, “seek”, “strive”, “will”, “may” and “should” and similar expressions. In particular, the forward-looking statements contained in this press release include statements referring to the impact of the acquisition on Reliance.

Although Brookfield believes that such forward-looking statements are based upon reasonable estimates, beliefs and assumptions, certain factors, risks and uncertainties, which are described from time to time in our documents filed with the securities regulators in the United States and Canada, not presently known to Brookfield or that that Brookfield currently believes are not material, could cause actual results or events to differ materially from those contemplated or implied by forward-looking statements.

Readers are urged to consider these risks, as well as other uncertainties, factors and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements, which are based only on information available to Brookfield as of the date of this press release. Except as required by law, Brookfield undertakes no obligation to publicly update or revise any forward-looking statements, whether written or oral, that may be as a result of new information, future events or otherwise.

Expanded solution includes new FlexGen Multi-Die product to address the challenge of efficient data movement for an industry that is shifting to multi-die architectures, while preserving quality of service and architectural flexibility across chip boundaries

CAMPBELL, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) — Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, today announced an expansion of its multi-die portfolio that helps semiconductor companies transition from monolithic system-on-chip (SoC) designs to chiplet-based architectures for AI, HPC and consumer electronics applications, without having to reinvent how data moves through the system.

Semiconductor companies are increasingly adopting multi-die architectures to address the demands of AI computing. They are now building systems that extend beyond the practical size limits of a single die, optimizing individual chiplets for different process technologies and dividing a system across multiple dies. This introduces a new challenge: communication that previously occurred within one SoC must now cross physical chip boundaries, while maintaining performance, efficiency, and predictable traffic behavior.

Arteris addresses this challenge by extending network-on-chip (NoC) connectivity and data movement transparently across die-to-die links, allowing multiple dies to operate as a unified architecture. The new FlexGen Multi-Die product expands this approach for non-coherent AI and high-performance computing architectures and complements Ncore Multi-Die for cache-coherent systems.

Together with Arteris Magillem integration automation and Cycuity hardware security assurance, the expanded portfolio provides semiconductor engineering teams with technologies spanning data movement, system integration, and security for increasingly complex multi-die designs.

“Multi-die architectures represent one of the most important changes in semiconductor design since the introduction of the SoC itself,” said K. Charles Janac, president and CEO of Arteris. “As systems expand beyond the boundaries of a single piece of silicon, the challenge is no longer simply connecting chiplets; it is preserving the intelligence of the architecture across them. Our goal is to help engineering teams gain the benefits of multi-die architectures without having to reinvent the system every time they divide it across another piece of silicon.”

Extending NoC interconnect technology across chip boundaries

In a monolithic SoC, NoC technology serves as the fabric that enables processors, memory subsystems, accelerators and other functions to communicate and share data. Moving to a multi-die architecture creates physical boundaries between those functions, potentially requiring engineering teams to define and manage additional interfaces between chiplets.

Arteris extends NoC connectivity transparently across those boundaries, without reinventing the system. The new FlexGen Multi-Die NoC IP supports bidirectional transactions over a single UCIe PHY, reducing PHY area, power and I/O requirements by up to 50%. This approach allows engineering teams to preserve important NoC capabilities across die-to-die links, rather than treating each chiplet boundary as a separate system integration problem.

FlexGen Multi-Die is designed for non-coherent AI and HPC architectures and supports virtual channel link technology to improve utilization of limited chiplet I/O resources and advanced quality-of-service (QoS) mechanisms that maintain throughput for high-priority traffic across shared die-to-die links. These capabilities help engineering teams use available bandwidth efficiently, while scaling designs across multiple dies.

The broader Arteris multi-die portfolio includes:

  • FlexGen Multi-Die for non-coherent AI and HPC architectures, extending efficient data movement and QoS capabilities across die boundaries.
  • Ncore Multi-Die for cache-coherent compute architectures, enabling coherent connectivity and efficient data sharing across multiple dies.
  • Magillem integration automation, which helps automate IP packaging, chiplet and multi-die integration, and hardware/software integration to reduce engineering effort and development complexity.
  • Cycuity hardware security assurance*, which helps engineering teams identify vulnerabilities earlier in development and verify security requirements across increasingly complex multi-die systems.

Together, these capabilities give semiconductor companies a more evolutionary path from monolithic SoCs to multi-die architectures, while helping engineering teams improve design reuse, reduce integration complexity and bring differentiated products to market faster.

From monolithic designs to multi-die products

Arteris customers are already using the company’s technology as they transition existing architectures from single-die implementations to multi-die products.

“As Agentic AI workloads continue to expand across cloud infrastructure, edge and endpoint devices, multi-die architectures are becoming increasingly important for balancing performance, scalability, and development efficiency,” said Jason Miller, senior director, Silicon Design at AMD. “Solutions that simplify system integration, while preserving bandwidth and performance across chiplets, help engineering teams accelerate innovation and bring differentiated products to market faster. Arteris’ continued expansion of its multi-die portfolio supports the flexibility and productivity required for our next generation of data center, client, gaming, and embedded compute products.”

“The future of advanced semiconductor design is inherently multi-die” said Daisuke Murakami, executive chief engineer, Global Leading Group at Socionext. By collaborating with Arteris on its UCIe-based multi-die solution, we gain early access to technologies that simplify chiplet integration while enabling the scalability, bandwidth and efficiency needed for next-generation AI, automotive and data-center SoCs.”

Building toward a broader chiplet ecosystem

As multi-die adoption expands, interoperability among NoC technologies, die-to-die interfaces, chiplet IP, design tools and advanced packaging technologies will become increasingly important. Arteris is working with semiconductor IP and ecosystem partners to help reduce integration risk and establish more reusable foundations for multi-die design.

“Physical AI systems require right-sized inference and scalable architectures that seamlessly integrate diverse compute technologies while meeting stringent power, performance, safety, security, and reliability requirements,” said David Glasco, vice president of R&D, Silicon Solutions Group at Cadence. “By combining the comprehensive Cadence Physical AI platform, IP, and security solutions with Arteris’ NoC IP, our collaboration enables accelerated silicon realization and trusted system deployment from cloud to edge. This reusable foundation helps customers scale physical AI systems more efficiently, reduce development risk, and speed time to market. Together, Cadence and Arteris provide a seamless path from specification to silicon to deployment, accelerating innovation across the physical AI ecosystem.”

“An open chiplet ecosystem requires architectural frameworks that simplify the integration of specialized dies into scalable, manufacturable systems,” said Suresh Subramaniam Ph.D., CTO, systems and advanced packaging at Silitronics. “We plan to leverage Arteris FlexGen technology in our development of an OCP-derived chiplet architecture, combining intelligent die-to-die connectivity with Silitronics’ system-level design, advanced packaging and heterogeneous integration capabilities to help customers bring differentiated multi-die solutions to market faster.”

“As multi-die designs become increasingly central to AI and high-performance computing innovation, interoperability across the chiplet ecosystem is critical to reducing design complexity and accelerating adoption,” said Neeraj Paliwal, senior vice president of product management at Synopsys. “The successful validation of interoperability between Synopsys’ silicon-proven UCIe IP, delivering high-bandwidth, low-latency die-to-die connectivity, and Arteris Ncore Cache Coherent NoC IP for multi-die designs helps customers confidently integrate chiplets, reduce integration risk, and enable silicon success.”

“UCIe provides an open, high-performance foundation for integrating chiplets across different functions and process technologies,” said Mao Liu, vice president at UniVista. “By working with Arteris to validate interoperability between UniVista UCIe IP and Arteris Ncore Multi-Die, we aim to provide customers with a more integrated path to scalable, cache-coherent multi-die designs for AI, high-performance computing and other compute-intensive applications.”

A practical path to the chiplet future

AI compute systems of the future require the transparent data movement solutions that Arteris is bringing to the industry, to speed the development and delivery of advanced heterogeneous systems. The new FlexGen Multi-Die product transparently extends non-coherent connectivity across die boundaries, enabling engineering teams to address different connectivity requirements across future multi-die SoC implementations. 

The expanded Arteris multi-die solution is available today to early access partners and strategic customers. Learn more at arteris.com/multi-die.

About Arteris

Arteris is a leading provider of semiconductor technology that accelerates the creation of high-performance, power-efficient silicon with built-in safety, reliability, and security. Innovative Arteris products are designed to optimize data movement and help ease complexity in the modern AI era with network-on-chip (NoC) interconnect intellectual property (IP), system-on-chip (SoC) software for integration automation and hardware security assurance. All are used by the world’s top technology companies to improve overall performance and engineering productivity, reduce risk, lower costs, and bring cutting-edge designs to market faster. Learn more at arteris.com.

© 2004-2026 Arteris, Inc. All rights reserved worldwide. Arteris, Arteris IP, the Arteris IP logo, and the other Arteris marks found at arteris.com/trademarks are trademarks or registered trademarks of Arteris, Inc. or its subsidiaries. All other trademarks are the property of their respective owners.

*Not available in all markets.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s expectations, plans, objectives, outlook, projected financial or operating results, market opportunities, product development, and/or business strategy. These statements are based on management’s current expectations, estimates, assumptions, and projections and are not historical facts. Words such as “may,” “will,” “could,” “would,” “expect,” “anticipate,” “believe,” “estimate,” “plan,” “intend,” “project,” “potential,” and similar expressions are intended to identify forward-looking statements.

These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including economic and market conditions; supply-chain constraints; technological developments; regulatory changes; litigation; cybersecurity risks; availability of capital; and other risks. Additional information regarding these and other risks is included in the Company’s filings with the Securities and Exchange Commission.

The forward-looking statements speak only as of the date of this press release. The Company undertakes no obligation to update or revise any forward-looking statement, except as required by applicable law.

Media Contact:
Gina Jacobs
Arteris
+1 408 560 3044
newsroom@arteris.com

This press release was published by a CLEAR® Verified individual.

SHANGHAI, Sept. 16, 2026 (GLOBE NEWSWIRE) — FREELANDER, the British Premium Intelligent All-Terrain Brand, is entering a new chapter with FREELANDER 8. Following extreme high-altitude and safety validation in China, the brand’s first strategic model has officially launched in the Chinese market, securing more than 10,000 orders within 48 hours. Now, FREELANDER 8 embarks on its next milestone, with its international variant set to be presented in Abu Dhabi as FREELANDER advances its entry into the Middle East.

Image 1_Guinness World Record

Before reaching the market, FREELANDER 8 demonstrated its all-terrain capability under extreme high-altitude conditions. The vehicle completed a demanding climbing challenge at an altitude of 6,002.33 metres, earning a Guinness World Records title for the highest altitude achieved in a hybrid car. The record was set in the Xizang Autonomous Region, China, in August 2026, where low oxygen, extreme temperatures and low-grip surfaces tested the vehicle’s stability at the edge of its operating limits. Conducted in low-oxygen, snowy and low-grip conditions, the challenge validated the vehicle’s Intelligent All-Terrain System (i-ATS), featuring nine terrain modes, a virtual central lock, rear electronic limited-slip differential (e-LSD) and dual-chamber air suspension.

Safety was validated through a demanding rollover crash test. After completing multiple consecutive rollovers on a steep outdoor slope, FREELANDER 8 maintained the integrity of its body structure, while the high-voltage system disconnected, the battery recorded no leakage or thermal runaway and the doors remained operable. The vehicle subsequently completed further driving validation, providing another demonstration of its safety engineering in extreme user scenarios. This test is part of FREELANDER’s commitment to global safety and quality standards, under which the model is built to meet global five-star safety standards across multiple global certification programs.

Image 2_Rollover Crash Test

These milestones were followed by FREELANDER 8’s China launch on September 3, which drew strong initial market acceptance of Legend Reborn. Following its China launch, FREELANDER 8 is now preparing for the next stage of its international journey. The Middle East represents a key step in FREELANDER’s global expansion, with the UAE serving as the brand’s first international market. The upcoming FREELANDER Global Brand Launch in Abu Dhabi will introduce the international variant of the FREELANDER 8 to wider audiences, marking another important step forward for the brand’s expansion across the world.

From extreme validation in China to its upcoming arrival in the Middle East, FREELANDER 8 enters its next chapter — a Legend Reborn, built on British Craftsmanship, Smart Confidence and All-Terrain Freedom for Freedom Seekers worldwide.

About FREELANDER

FREELANDER is a British Premium Intelligent All-Terrain brand co-created by Chery and Jaguar Land Rover. JLR leads the design and premium DNA, while Chery brings advanced technology and global top-tier supply chain capabilities. The brand is supported by a strong global foundation, including over 5,000 employees, five strategic hubs, and fully integrated capabilities spanning design, R&D, manufacturing, and global operations.

Vincent CHEN
freelander.international@mychery.com
https://www.cheryinternational.com/

Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/ebc9f0f3-6aa3-46d8-8318-ae153523a920
https://www.globenewswire.com/NewsRoom/AttachmentNg/f4060ff5-81b6-4cb7-9c17-d7032e8e419f

CARLSBAD, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) — Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” ), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today filed a patent infringement lawsuit against DeGen Medical, Inc. (“DeGen”) in the United States District Court for the District of South Carolina Florence Division.

The complaint asserts that DeGen is infringing eight of Carlsmed’s patents relating to its implants, methods and systems. Carlsmed is seeking injunctive relief and damages for infringement.

“Carlsmed is dedicated to advancing the standard of care in spine surgery through our proprietary personalized spine surgery solutions and bringing value to patients, surgeons, and payors every day. We are committed to protecting the intellectual property that supports our patient-centric innovation, which remains at the forefront of the industry,” said Mike Cordonnier, Chairman and CEO of Carlsmed.

About Carlsmed, Inc.

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Forward Looking Statements

Any statements in this press release about future expectations, plans and prospects, including statements about Carlsmed’s ability to scale its business and other statements containing the words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “target,” “potential,” “likely,” “will,” “would,” “could,” “should,” “continue,” and similar expressions, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including such important factors as are set forth under the caption “Risk Factors” in Carlsmed’s Annual Report on Form 10-K on file with the U.S. Securities and Exchange Commission. The forward-looking statements included in this press release represent Carlsmed’s views as of the date of this press release. Carlsmed anticipates that subsequent events and developments will cause its views to change. However, while Carlsmed may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Carlsmed’s views as of any date subsequent to the date of this press release.

Investor Relations
IR@Carlsmed.com

Media
media@Carlsmed.com

WINTER PARK, Fla., Sept. 15, 2026 (GLOBE NEWSWIRE) — Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a technology company building the future of the commodity markets through tokenization, today announced that Henry McPhie, Chief Executive Officer, will present and host one-on-one meetings with investors at Sidoti’s Small-Cap Virtual Investor Conference, taking place on September 23, 2026.

Presentation Details

The live presentation will begin at 1:45 p.m. ET on Wednesday, September 23, 2026 and can be accessed live here: Live Webcast Link. Streamex will also host virtual one-on-ones with investors on Wednesday September 23, 2026. To register for the presentation or one-on-ones, visit www.sidoti.com/events. Registration is free and you don’t need to be a Sidoti client.

About Sidoti Events, LLC (“Events”) and Sidoti & Company, LLC (“Sidoti”)

In 2023, Sidoti & Company, LLC formed an affiliate company, Sidoti Events, LLC in order to focus exclusively on its rapidly growing conference business and to more directly serve the needs of presenters and attendees. The relationship allows Events to draw on the over 25 years of experience Sidoti has as a premier provider of independent securities research focused specifically on small and microcap companies and the institutions that invest in their securities, with most of its coverage in the $200 million-$5 billion market cap range. Sidoti’s coverage universe comprises approximately 110 equities, of which more than 80 percent participate in the firm’s rapidly growing Company Sponsored Research (“CSR”) program. Events is a leading provider of corporate access through the many investor conferences it hosts each year. By virtue of its direct ties to Sidoti, Events benefits from Sidoti’s small- and microcap-focused nationwide sales force, which has connections with over 2,500 institutional relationships in North America. This enables Events to provide multiple forums for meaningful interaction for small and microcap issuers and investors specifically interested in companies in the sector.

About Streamex Corp.

Streamex Corp. (NASDAQ: STEX) is a technology and infrastructure company focused on the tokenization and digitalization of commodity real-world assets. Streamex delivers institutional-grade solutions that bridge traditional finance and blockchain-enabled markets through secure, regulated, and yield-bearing financial instruments.

For more information, visit www.streamex.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Streamex’s business strategy, product development, and participation in the Sidoti Small-Cap Virtual Investor Conference. These statements are based on current expectations and assumptions subject to risks and uncertainties beyond Streamex’s control, and actual results may differ materially, including as a result of market conditions, regulatory developments, and macroeconomic factors affecting digital asset markets. A discussion of these and other factors is set forth in Streamex’s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Streamex undertakes no obligation to update any forward-looking statements except as required by law.

Contacts

Laura Kiernan Henry McPhie
Head of Investor Relations, Streamex Corp. Chief Executive Officer, Streamex Corp.
IR@streamex.com | 1-914-598-7733 www.streamex.com | X.com/streamex

TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) — Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”), today announced that it has received notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company is eligible for an additional 180-calendar-day period, or until March 15, 2027 (the “Extension”), to regain compliance with Nasdaq’s $1.00 minimum bid price requirement (the “Minimum Bid Price Requirement”) for continued listing on Nasdaq.

The Extension has no immediate effect on the listing or trading of the Company’s common shares (the “Shares”) on Nasdaq, and the Company’s operations are not affected by the receipt of the Extension.

Nasdaq’s determination is based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on The Nasdaq Capital Market, other than the Minimum Bid Price requirement, together with the Company’s written notice of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.

If at any time before March 15, 2027, the closing bid price of the Shares is at or above US$1.00 per Share for a minimum of 10 consecutive business days, the Company will be eligible to regain compliance with the Minimum Bid Requirement, subject to Nasdaq’s discretion to require a longer compliance period. The Extension does not have any impact on the listing of the Shares on the TSX Venture Exchange.

About Electra Battery Materials

Electra is a leader in advancing North America’s critical minerals supply chain for lithium-ion batteries. The Company’s primary focus is constructing North America’s only cobalt sulfate refinery, as part of a phased strategy to onshore critical minerals refining and reduce reliance on foreign supply chains. In addition to the Refinery, Electra holds a significant land package in Idaho’s Cobalt Belt, including its Iron Creek project and surrounding properties, positioning the Company as a potential cornerstone for North American cobalt and copper production.

Electra is also advancing black mass recycling opportunities to recover critical materials from end-of-life batteries, while continuing to evaluate growth opportunities in nickel refining and other downstream battery materials. For more information, please visit www.ElectraBMC.com.

Contact
Heather Smiles
Vice President, External Affairs & Corporate Development
Electra Battery Materials
info@ElectraBMC.com
1.416.900.3891

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Statements

This news release may contain forward-looking statements and forward-looking information (together, “forward-looking statements”) within the meaning of applicable securities laws and the United States Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, are forward-looking statements. Generally, forward-looking statements can be identified by the use of terminology such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words, or statements that certain actions, events or results “may”, “could”, “would”, “might”, “occur” or “be achieved”. Forward-looking statements are based on certain assumptions, and involve risks, uncertainties and other factors that could cause actual results, performance, and opportunities to differ materially from those implied by such forward-looking statements. Factors that could cause actual results to differ materially from these forward-looking statements are set forth in the management discussion and analysis and other disclosures of risk factors for Electra Battery Materials Corporation, filed on SEDAR+ at www.sedarplus.com and with EDGAR at www.sec.gov. There can be no assurance that the Company will regain compliance with the Minimum Bid Price Requirement within the applicable compliance period or at all. Although the Company believes that the information and assumptions used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Except where required by applicable law, the Company disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.